
Yen and Euro Boosted by Progress in Trade Talks
The euro edged toward its highest level in nearly four years on Thursday, while the yen held onto its gains following progress in trade agreements between the United States and its key trading partners, improving overall market sentiment.Currencies largely shrugged off reports that U.S. President Donald Trump would visit the Federal Reserve on Thursday. Trump has frequently criticized Fed Chair Jerome Powell for not cutting interest rates.It remains unclear whether Trump will actually meet with Powell.Markets are closely monitoring developments in tariff negotiations. On Wednesday, two European diplomats said the European Union and the United States are close to finalizing a trade deal that could involve a 15% U.S. tariff on EU goods, along with potential exemptions.This follows the trade agreement between Washington and Tokyo, which includes tariff reductions on Japanese car imports and exemptions from new duties on other goods, in exchange for a $550 billion package of investments and loans.Global markets responded positively to the latest developments, with risk assets climbing and investors selling off the U.S. dollar.The Australian dollar rose to its highest level in eight months at $0.66135 on Thursday.The euro held steady at $1.1776, hovering near the earlier-month peak of $1.1830, its strongest level in more than three years.'These agreed trade frameworks between the U.S. and major economies are certainly positive for risk sentiment,' said Carol Kong, currency strategist at the Commonwealth Bank of Australia.'We had expected the risk of a showdown between the U.S. and the EU… but it seems that risk has faded,' she added.Against the yen, the dollar dropped 0.3% to 146.01, continuing its slide against the Japanese currency for the fourth consecutive session.While news of the trade agreement lifted local equities, lingering political uncertainty in Japan limited the yen's gains.Japanese Prime Minister Shigeru Ishiba on Wednesday denied reports that he planned to resign, following claims from a source and media reports suggesting he intended to step down in the wake of a bitter defeat in the House of Councillors election.The British pound was steady at $1.3581 after rising 0.36% in the previous session.The U.S. dollar index slipped slightly to 97.15, while the New Zealand dollar edged up 0.11% to $0.6053.In addition to trade talks, markets are also focused on the European Central Bank's interest rate decision, expected later on Thursday.Reuters
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Jordan Times
7 hours ago
- Jordan Times
AstraZeneca quarterly net profit jumps on record US growth
LONDON — British pharmaceutical giant AstraZeneca on Tuesday said net profit rose 27 per cent in the second quarter, boosted by record growth in its key US market. Profit after tax rose to $2.45 billion in the three months to the end of June, the company said in an earnings statement, following its recently announced multi-billion-dollar investment in the United States. Total revenue climbed 12 per cent to a quarterly record of $14.5 billion, driven by strong cancer drug sales. Amid the threat of President Donald Trump's possible tariffs on pharmaceutical imports, AstraZeneca has unveiled plans to invest $50 billion in the US by 2030 and has already began moving some of its European production to the US. Chief executive Pascal Soriot said the "landmark investment reflects not only America's importance but also our confidence in our innovative medicines." The United States, a critical market for the pharmaceutical industry, accounted for 44 per cent of AstraZeneca's total revenue in the second quarter, with US revenue jumping a record 13 per cent. The company expects half of its revenue to come from the US by 2030. Trump has ordered an investigation into potential tariffs on pharmaceutical imports, which had so far benefited from exemptions to his sweeping levies on imports from trading partners. He suggested that levies on the sector could reach up to 200 per cent. Washington and Brussels announced a trade agreement on Sunday that places 15 per cent tariffs on pharmaceutical imports from the European Union to the US. Other major pharmaceutical companies — including Swiss giants Roche and Novartis, and France's Sanofi — have also begun shifting investment and production to the United States in recent months.


Jordan News
17 hours ago
- Jordan News
Oil Prices Steady Amid Economic Uncertainty and Anticipation of U.S. Interest Rate Decision - Jordan News
Oil prices held steady on Tuesday as markets remained cautious about global economic prospects following a trade agreement between the United States and the European Union, while investors awaited the upcoming decision from the U.S. Federal Reserve on interest rates. اضافة اعلان Brent crude futures rose by one cent, reaching $70.05 per barrel at 06:10 GMT, while West Texas Intermediate (WTI) crude edged down two cents to $66.69 per barrel. Both benchmarks had closed the previous session up by more than 2%, with Brent reaching a recent high. Although the trade deal between Washington and Brussels includes a 15% tariff on most European goods, it helped avert a full-blown trade war that could have endangered a third of global trade and weakened fuel demand. The agreement also outlines a commitment by the EU to purchase $750 billion worth of U.S. energy over the coming years—a target analysts describe as nearly impossible—in addition to $600 billion in European investments in the U.S. during President Donald Trump's second term. According to an analytical note from ANZ Bank, 'While the agreement provided relief to global markets amid persistent uncertainty, the timeline for implementing the investment commitments remains vague. We believe the 15% tariff will challenge eurozone economic growth but is unlikely to trigger a recession.' Meanwhile, senior economic officials from the U.S. and China met in Stockholm on Monday for more than five hours of discussions aimed at resolving ongoing economic disputes, with talks expected to resume on Tuesday. Oil market participants are also closely watching the Federal Open Market Committee (FOMC) meeting on July 29–30, amid expectations that interest rates will remain unchanged. However, analysts suggest the Fed may adopt a more dovish tone due to declining inflation indicators, according to Priyanka Sachdeva, market analyst at Phillip Nova. Sachdeva added, 'Momentum is skewed toward the upside in the short term, but the market remains vulnerable to volatility from surprise central bank moves or failed trade negotiations.' In another development, companies involved in global green hydrogen projects have begun canceling or scaling back investments, signaling that reliance on fossil fuels may persist longer than globally anticipated. Additionally, U.S. President Donald Trump on Monday gave Russia a new deadline of '10 to 12 days' to make progress in ending the war in Ukraine, threatening new sanctions on Moscow and on countries that continue buying Russian exports if no progress is made, according to Reuters.

Ammon
20 hours ago
- Ammon
Oil slips amid economic concerns, US rate decision awaited
Ammon News - Oil prices slipped on Tuesday amid uncertainty about the global economic outlook following the U.S.-EU trade deal, and as investors awaited the U.S. Federal Reserve's interest rate decision. Brent crude futures were down 6 cents, or 0.1%, to $69.98 a barrel at 0425 GMT, while U.S. West Texas Intermediate crude was at $66.60, down 11 cents, or 0.2%. Both contracts settled more than 2% higher in the previous session, and Brent touched its highest level since July 18 on Monday. The trade agreement between the United States and the European Union, while imposing a 15% import tariff on most EU goods, sidestepped a full-blown trade war between the two major allies that would have rippled across nearly a third of global trade and dimmed the outlook for fuel demand. Reuters